Public Notices: Peak Powder River Resources, LLC (F031172/A0016113)
Clinical Efficacy Endpoints from the Phase 3 CANOPY Study Evaluating[...]
Pharmacokinetics and Serum Virus Neutralizing Antibody Titers Following[...]
12/23/2022 | Press release | Distributed by Public on 12/23/2022 02:29
Please select the service you want to use:
Smartlinks | HanseYachts AG | Finance | Security Markets | Derivative Securities | Security Markets | Company News | Shareholders | Shareholder Meeting | Manufacturing | Lifestyle and Leisure | Boating and Yachting | Public Companies | Boat Industries | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | BX Swiss | Tradegate Exchange | XETRA | Börse Hamburg | Cboe Off Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact